Idiopathic Pulmonary Fibrosis (IPF)

image description

Idiopathic pulmonary fibrosis (IPF) is one of more than 130 types of interstitial lung disease (ILD). It is described by scarring (fibrosis) of the lungs. The word “idiopathic” means “of unknown cause.”

National Jewish Health is the leading hospital in the nation. We treat hundreds of people with IPF and other types of pulmonary fibrosis each year. Our expertise is recognized by the Pulmonary Fibrosis Foundation (PFF). It has designated National Jewish Health as a PFF Care Center.

National Jewish Health also is a Specialized Center of ILD Research for the National Institutes of Health. This center conducts IPF research, so you have access to the latest clinical trials and most effective treatments.


Idiopathic Pulmonary Fibrosis Care

At National Jewish Health, you’ll find:

  • The latest clinical trials
  • Newest treatment options
  • Individualized care
  • A team of different specialists working together to care for you
  • Radiologists with special expertise in IPF
  • The ability to diagnose IPF early and correctly
  • State-of-the-art pulmonary testing and treatments
  • Comprehensive pulmonary rehabilitation services
  • Support groups

Learn more about the Interstitial Lung Disease (ILD) Program.

Our Specialists

Clinical Trials

Pulmonary Fibrosis & Genetic Factors

The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.

Learn More

Reasons to Visit National Jewish Health

  • The leading respiratory hospital in the nation and the only one devoted fully to the treatment of respiratory and related illnesses
  • Ranked as one of the top two hospitals in pulmonology every year since U.S. News & World Report included this category in its annual “Best Hospitals” survey
  • Ranked in the top 1 percent of hospitals in the nation by HCAHPS
  • Physicians frequently recognized as among the best in the nation by multiple services, including Best Doctors in America and Castle Connolly
  • Among the top 8 percent of organizations funded for research by the NIH, providing patients access to the latest clinical trials
  • 119 -year history of focus on care, research and education serving thousands of patients with lung, heart, immune and related disorders


Patient Stories

Finding Hope for Himself and Others

Four years ago, Mark McCormick started having a persistent cough. His primary care doctor ordered a chest x-ray; however, he never received the results. A year later, Mark learned that he had idiopathic pulmonary fibrosis. “It took my breath away,” he said, but it didn’t stop him from seeking help and supporting other people like him.

Read More View All Patient Stories

Health Insights & News

Giving Help us care for patients with idiopathic pulmonary fibrosis. Ways to Give

#Men are nearly twice as likely as women to suffer from #IPF.

Tweet this
Featured Health Insight

Living with Idiopathic Pulmonary Fibrosis (IPF)

Living with chronic lung disease changes a person's life and requires adjusting to a new way of being in the world.

Learn More